Appendix 4C - quarterly
Released
Released
Announcement PDF
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
+Rule 4.7B
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16
Name of entity
Imagion Biosystems Limited
ABN
Quarter ended (“current quarter”)
42 616 305 027
30 June 2018
Current quarter
$A’000
Year to date
(6 months)
$A’000
2
26
(485)
(1,078)
-
-
(c) advertising and marketing
(33)
(63)
(d) leased assets
(3)
(5)
(e) staff costs
(1,071)
(1,740)
(f)
(333)
(530)
Consolidated statement of cash flows
1.
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
(a) research and development
(b) product manufacturing and operating
costs
administration and corporate costs
1.3
Dividends received (see note 3)
-
-
1.4
Interest received
10
55
1.5
Interest and other costs of finance paid
(1)
(2)
1.6
Income taxes paid
-
-
1.7
Government grants and tax incentives
-
-
1.8
Other (GST Refund)
10
20
1.9
Net cash from / (used in) operating
activities
(1,904)
(3,317)
2.
Cash flows from investing activities
2.1
Payments to acquire:
(32)
(33)
(b) businesses (see item 10)
-
-
(c) investments
-
-
(a) property, plant and equipment
+ See chapter 19 for defined terms
1 September 2016
Page 1
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
Current quarter
$A’000
Year to date
(6 months)
$A’000
(d) intellectual property
-
-
(e) other non-current assets
-
-
(a) property, plant and equipment
-
-
(b) businesses (see item 10)
-
-
(c) investments
-
-
(d) intellectual property
-
-
(e) other non-current assets
-
-
2.3
Cash flows from loans to other entities
-
-
2.4
Dividends received (see note 3)
-
-
2.5
Other (provide details if material)
-
-
2.6
Net cash from / (used in) investing
activities
(32)
(33)
3.
Cash flows from financing activities
3.1
Proceeds from issues of shares
-
-
3.2
Proceeds from issue of convertible notes
-
-
3.3
Proceeds from exercise of share options
-
-
3.4
Transaction costs related to issues of
shares, convertible notes or options
-
-
3.5
Proceeds from borrowings
-
-
3.6
Repayment of borrowings
(9)
(49)
3.7
Transaction costs related to loans and
borrowings
-
-
3.8
Dividends paid
-
-
3.9
Other (provide details if material)
-
-
3.10
Net cash from / (used in) financing
activities
(9)
(49)
4.
Net increase / (decrease) in cash and
cash equivalents for the period
4.1
Cash and cash equivalents at beginning of
quarter/year to date
5,527
6,901
Consolidated statement of cash flows
2.2
Proceeds from disposal of:
4.2
Net cash from / (used in) operating
activities (item 1.9 above)
(1,904)
(3,317)
4.3
Net cash from / (used in) investing activities
(item 2.6 above)
(32)
(33)
4.4
Net cash from / (used in) financing activities
(item 3.10 above)
(9)
(49)
+ See chapter 19 for defined terms
1 September 2016
Page 2
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
Consolidated statement of cash flows
Current quarter
$A’000
Year to date
(6 months)
$A’000
4.5
Effect of movement in exchange rates on
cash held
24
104
4.6
Cash and cash equivalents at end of
quarter
3,606
3,606
5.
Reconciliation of cash and cash
equivalents
Current quarter
$A’000
Previous quarter
$A’000
at the end of the quarter (as shown in the
consolidated statement of cash flows) to the
related items in the accounts
5.1
Bank balances
3,606
5,527
5.2
Call deposits
-
-
5.3
Bank overdrafts
-
-
5.4
Other (provide details)
-
-
5.5
Cash and cash equivalents at end of
quarter (should equal item 4.6 above)
3,606
5,527
6.
Payments to directors of the entity and their associates
Current quarter
$A’000
6.1
Aggregate amount of payments to these parties included in item 1.2
132
6.2
Aggregate amount of cash flow from loans to these parties included
in item 2.3
-
6.3
Include below any explanation necessary to understand the transactions included in
items 6.1 and 6.2
Relates to director’s remuneration and expense reimbursements for the group.
Current quarter
$A'000
7.
Payments to related entities of the entity and their
associates
7.1
Aggregate amount of payments to these parties included in item 1.2
-
7.2
Aggregate amount of cash flow from loans to these parties included
in item 2.3
-
7.3
Include below any explanation necessary to understand the transactions included in
items 7.1 and 7.2
+ See chapter 19 for defined terms
1 September 2016
Page 3
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
8.
Financing facilities available
Add notes as necessary for an
understanding of the position
Total facility amount
at quarter end
$A’000
Amount drawn at
quarter end
$A’000
8.1
Loan facilities
-
-
8.2
Credit standby arrangements
-
-
8.3
Other (please specify)
-
-
8.4
Include below a description of each facility above, including the lender, interest rate and
whether it is secured or unsecured. If any additional facilities have been entered into or are
proposed to be entered into after quarter end, include details of those facilities as well.
9.
Estimated cash outflows for next quarter
$A’000
9.1
Research and development
(436)
9.2
Product manufacturing and operating costs
9.3
Advertising and marketing
(43)
9.4
Leased assets
(9)
9.5
Staff costs
(587)
9.6
Administration and corporate costs
(324)
9.7
Other (provide details if material)
-
9.8
Total estimated cash outflows
(1,399)
10.
Acquisitions and disposals of
business entities
(items 2.1(b) and 2.2(b) above)
10.1
Name of entity
10.2
Place of incorporation or
registration
10.3
Consideration for acquisition or
disposal
10.4
Total net assets
10.5
Nature of business
+ See chapter 19 for defined terms
1 September 2016
-
Acquisitions
Disposals
Page 4
Appendix 4C
Quarterly report for entities subject to Listing Rule 4.7B
Compliance statement
1
This statement has been prepared in accordance with accounting standards and policies which
comply with Listing Rule 19.11A.
2
This statement gives a true and fair view of the matters disclosed.
Sign here:
............................................................
Director
Print name:
Robert Proulx
Date: 27 July 2018
Notes
1.
The quarterly report provides a basis for informing the market how the entity’s activities have been
financed for the past quarter and the effect on its cash position. An entity that wishes to disclose
additional information is encouraged to do so, in a note or notes included in or attached to this
report.
2.
If this quarterly report has been prepared in accordance with Australian Accounting Standards,
the definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If
this quarterly report has been prepared in accordance with other accounting standards agreed by
ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standard applies to this
report.
3.
Dividends received may be classified either as cash flows from operating activities or cash flows
from investing activities, depending on the accounting policy of the entity.
+ See chapter 19 for defined terms
1 September 2016
Page 5
Share your feedback
Discover